Gilead (GILD), Amgen (AMGN) and Vertex Pharmaceuticals (VRTX) are some of the most trending stocks in the biotech sector. See how they compare to other companies such as Biogen (BIIB), Illumina (ILMN) and Regeneron (REGN).
Which Biotech stocks have a "Strong Buy" analyst rating?
These Biotech stocks currently have a "Strong Buy" analyst rating consensus:
Regeneron - Strong Buy, based on 22 analyst ratings, 18 Buy, 3 Hold, and 1 Sell.
IQVIA Holdings - Strong Buy, based on 16 analyst ratings, 14 Buy, 2 Hold, and 0 Sell.
Are Biotech stocks overpriced?
Gilead Sciences's stock price is currently $73.26, and its average 12-month price target is $85.78.
Amgen's stock price is currently $270.90, and its average 12-month price target is $312.00.
Vertex Pharmaceuticals's stock price is currently $411.38, and its average 12-month price target is $435.60.
Biogen's stock price is currently $219.40, and its average 12-month price target is $293.41.
Illumina's stock price is currently $130.14, and its average 12-month price target is $153.38.
Regeneron's stock price is currently $959.92, and its average 12-month price target is $1,036.77.
Moderna's stock price is currently $104.26, and its average 12-month price target is $132.43.
IQVIA Holdings's stock price is currently $253.87, and its average 12-month price target is $277.50.
BioNTech SE's stock price is currently $92.99, and its average 12-month price target is $117.86.
Which Biotech stocks pay dividends?
Gilead Sciences does not currently pay dividends.
Amgen currently pays a dividend of $2.25 which represents an annual dividend yield of 3.21%. Amgen's next Ex-dividend date is May 16, 2024 and its next payout date is June 7, 2024.
Vertex Pharmaceuticals does not currently pay dividends.